Abstract
Background: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma).
Methods: Chine Hamster Ovary (CHO) cells were treated with F. haepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent.
Results: We observed unexpected death of these cells when treated with F. haepatica extracts.
Conclusion: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
Keywords: Fasciola hepatica, mammalian cells, cholangiocarcinoma, O. viverrini, C. sinensis, Chine Hamster Ovary (CHO).
Graphical Abstract
Anti-Infective Agents
Title:Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells
Volume: 16 Issue: 2
Author(s): Stephanie Ferreira, Ruben Fernandes and Monica C. Botelho*
Affiliation:
- I3S, Instituto de Investigacao e Inovacao da Universidade do Porto, Porto,Portugal
Keywords: Fasciola hepatica, mammalian cells, cholangiocarcinoma, O. viverrini, C. sinensis, Chine Hamster Ovary (CHO).
Abstract: Background: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma).
Methods: Chine Hamster Ovary (CHO) cells were treated with F. haepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent.
Results: We observed unexpected death of these cells when treated with F. haepatica extracts.
Conclusion: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
Export Options
About this article
Cite this article as:
Ferreira Stephanie , Fernandes Ruben and C. Botelho Monica *, Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells, Anti-Infective Agents 2018; 16 (2) . https://dx.doi.org/10.2174/1570180815666180531102555
DOI https://dx.doi.org/10.2174/1570180815666180531102555 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review
Current Drug Research Reviews Recent Developments in Protein and Cell-Targeted Aptamer Selection and Applications
Current Medicinal Chemistry Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Current Molecular Medicine Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Targeting Schistosome Histone Modifying Enzymes for Drug Development
Current Pharmaceutical Design Drug Conjugated Nanomedicine as Prodrug Carrier
Nanoscience & Nanotechnology-Asia Herbal Phytochemicals as Immunomodulators
Current Immunology Reviews (Discontinued) Is Src a Viable Target for Treating Solid Tumours?
Current Cancer Drug Targets A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
Current Cancer Drug Targets Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology What Does Systems Biology Mean for Drug Development?
Current Medicinal Chemistry Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review
Current Drug Delivery Cancer Stem Cells Switch on Tumor Neovascularization
Current Molecular Medicine Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy
Current Medicinal Chemistry Pharmacokinetics of CNT-based Drug Delivery Systems
Current Drug Metabolism The Role of Bax/Bcl-2 and Pro-Caspase Peptides in Hypoxia/Reperfusion-Dependent Regulation of MAPKERK: Discordant Proteomic Effect of MAPKp38
Protein & Peptide Letters The Diterpenoids of the Genus Elaeoselinum (Apiaceae) and their Biological Properties
Current Organic Chemistry Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics
Current Drug Targets Recent Advances in Delivery of Cytokines, Growth Factors, and Molecules of Therapeutic Interest from Hyaluronan-based Hydrogels
Current Tissue Engineering (Discontinued) Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold
Anti-Cancer Agents in Medicinal Chemistry